Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from AZN

AstraZeneca Plummets, Sacrificing A Breakout, On Mixed Results In Lung Cancer Treatment

AstraZeneca and Daiichi Sankyo reported mixed results Monday from a final-phase study of their lung cancer treatment, and AZN stock tumbled.

Investors Business Daily

3 Medical Stock Picks for Investors

As the demand for healthcare products and solutions continues to rise, the medical industry is poised for remarkable growth. Therefore, quality medical stocks Johnson & Johnson (JNJ), AstraZeneca (AZN), and Astellas Pharma (ALPMY) could be the ideal investments for your portfolio amid current market uncertainties. Read on….

StockNews.com

3 Stocks to Protect Your Portfolio Amid Inflation Concerns

Despite showing signs of cooling down, inflation remains a concern for the Fed as it is far off its 2% target. Investors looking to secure their portfolios against the expected market volatility due to the still-high inflation could consider fundamentally strong and dividend-paying stocks AstraZeneca (AZN), McDonald’s (MCD), and Flowers…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

AZN Stock Today: This Options Trade Boosts AstraZeneca Stock Yield To 21% Annualized

Selling the call option generates an income of 2.7% in just over one month.

Investors Business Daily

2 of the Best Biotech Stocks to Buy This Month

The biotech industry is growing thanks to breakthrough advancements and government initiatives. Furthermore, during market downturns, the biotech sector is more defensive than others. So, fundamentally sound biotech stocks Pfizer (PFE) and AstraZeneca (AZN) could be worth buying. Read on.

StockNews.com

Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian Cancer

AstraZeneca said Wednesday a combination of its drugs Lynparza and Imfinzi met the goal of a key study, leading AZN stock to surge.

Investors Business Daily

4 Best Pharma Stocks to Buy for the Long Haul

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy is likely to enter a recession, making pharma stocks attractive investment options. Therefore, investors could look to…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Best Stocks to Buy Now for Long-Term Investors

Recent turmoil in the financial sector, renewed recession worries, and the Fed’s continued rate hikes paint an unfavorable picture for the stock market and economy. Amid this, long-term investors could opt for fundamentally sound stocks AstraZeneca (AZN), Cisco Systems (CSCO), and Ambev (ABEV) to withstand ongoing macroeconomic headwinds. Read more….

StockNews.com

Don't Let These 2 Stocks Pass You by in 2023

With inflation remaining elevated, the Fed is expected to stay restrictive with its monetary policy. This is expected to keep the stock market volatile. Amid this backdrop, it could be wise for investors to buy fundamentally strong stocks AstraZeneca PLC (AZN) and General Motors Company (GM). Keep reading.

StockNews.com

The Best Stock to Buy for Under $100 Right Now

Strong fundamentals and bright prospects of AstraZeneca (AZN), trading below $100 a share, could help investors secure decent risk-adjusted returns on their investments in a choppy market environment. Read on….

StockNews.com

2 Pharma Stocks to Buy Right Now and 1 You Might Want to Consider Selling

The pharmaceutical industry is evolving with personalized medicines and the rapid adoption of RPM technology, which should boost growth. Moreover, with a recession lurking, fundamentally strong pharma stocks AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) might be ideal buys. However, SNDL (SNDL) might be best avoided. Keep reading to know why.

StockNews.com

2 Large-Cap Stocks You Can Buy for Under $100

While rising inflation and the Fed’s rate hikes are expected to keep the stock market volatile in the near term, large-cap stocks could help survive. Therefore, fundamentally sound large-cap stocks, Coca-Cola (KO) and AstraZeneca (AZN), which are currently trading under $100, might be solid additions to your portfolio. Keep reading.

StockNews.com

1 Pharma Stock Poised for a Promising 2023

Following a year of solid growth in 2022, leading pharma company AstraZeneca’s (AZN) robust pipeline and recent launches look promising. Moreover, its strong fundamentals should enable the stock to deliver solid returns this year. So, AZN could be an ideal buy. Keep reading.

StockNews.com

4 Pharma Stocks to Buy Now for the Long Haul

The pharma industry has experienced tremendous growth in recent years. The industry should continue to grow, driven by the growing market for personalized medicine and e-pharmacies. Hence, pharma stocks Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and Zoetis (ZTS) might be worth buying for the long term. Also, these companies…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Boost Your Portfolio With These Strong Buy Stocks

Expectations of the economy avoiding a recession have been rising amid the still-tight labor market and improving consumer sentiments. However, while uncertainties remain, quality stocks Walmart (WMT), AstraZeneca (AZN), and LSI Industries (LYTS), which are Strong Buy-rated in our proprietary system, could be ideal additions to boost your portfolios. Keep…

Investors Business Daily

AstraZeneca Hits Its Stride On Upbeat Guidance With 'Desirable' Growth

AstraZeneca's earnings topped forecasts Thursday, but sales came in light. AZN stock rose on its upbeat 2023 guidance.

StockNews.com

3 Stocks to Help You Build Wealth in the Market

Receding inflationary pressure and the Fed’s smaller rate hike have raised investor optimism. However, amid additional rate hike fears and associated volatilities, investors could scoop up quality stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and AstraZeneca (AZN) that could help them build wealth in the market. Read on….

StockNews.com

3 Pharma Stocks to Buy in 2023 and Hold for Decades

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

2 Pharma Stocks to Buy Now for Big Gains

The pharma industry is well-placed to benefit from the rise of chronic diseases and an aging population. Moreover, given the stable demand for medicines, the industry is relatively unaffected by macroeconomic uncertainty. Therefore, it could be wise for investors to buy fundamentally strong pharma stocks AstraZeneca (AZN) and Novartis (NVS).…

StockNews.com

4 Pharma Stocks You Shouldn’t Think Twice About Buying in 2023

Pharma sector usually performs relatively well amid market turmoil due to the inelastic demand for its offerings. Moreover, increased technological advancements should boost the industry’s growth. Hence, pharma stocks Eli Lilly (LLY), AstraZeneca (AZN), Zoetis (ZTS), and Teva Pharmaceutical (TEVA) might be worth buying in 2023. Read more.

Investors Business Daily

Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year?

As last year's bear market spills over into 2023, breakout index stocks like CAT, BOX, AZN and ELF stock show resilience.

Investors Business Daily

IBD 50 Stocks To Watch: Pharmaceutical Leader AstraZeneca Retakes Latest Buy Point

Among the top stocks to watch, pharmaceutical leader AstraZeneca is retaking its latest buy point despite Tuesday's stock market weakness.

StockNews.com

4 Pharmaceutical Stocks You Can Always Rely On

The pharmaceutical industry is well-positioned to witness substantial growth, driven by the prevalence of chronic diseases, the aging population, and increased healthcare spending. Given the industry’s promising growth prospects, we think it could be wise to invest in fundamentally sound pharmaceutical stocks Johnson & Johnson (JNJ), Merck & Co (MRK),…

StockNews.com

5 Amazing Stocks You Won’t Ever Regret Buying

Easing inflation and the Fed’s indication of slowing the pace of interest rate hikes are raising investors’ sentiments. Moreover, the November job report came in better than expected. While uncertainties remain, we think quality stocks Pfizer (PFE), AstraZeneca PLC (AZN), Carrier Global (CARR), J. Jill (JILL), and Lifeway Foods (LWAY)…

Investors Business Daily

AstraZeneca Makes A Break For A Buy Point On Massive Third-Quarter Growth

AstraZeneca leaned on cancer drugs in the third-quarter, leading to double-digit sales growth, a strong beat and a jump for AZN stock.

1 2 3 4

People

Sristi Suman Jayaswal

90 stories

Andrew Berens

18 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.